Advances in asthma drug discovery: Evaluating the potential of nasal cell sampling and beyond

Expert Opinion on Drug Discovery

Volumn 9, Issue 6, 2014, Pages 595-607

  Calzetta, Luigino ^a   Rogliani, Paola ^b   Cazzola, Mario ^b   Matera, Maria Gabriella ^c  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Allergic rhinitis; Artificial airways; Asthma; Inflammation; Nasal cells

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; PHOSPHORYL LIPID A; RANTES; RECOMBINANT ALLERGEN; VACCINE; ANTIASTHMATIC AGENT;

ALLERGIC RHINITIS; ANTIGEN PRESENTATION; ASTHMA; BIOCHIP; BRONCHUS; BRONCHUS BIOPSY; CYTOLOGY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDUSTRY; EVIDENCE BASED MEDICINE; GENE EXPRESSION; HISTAMINE RELEASE; HISTOLOGY; HUMAN; HYPEREMIA; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; INNATE IMMUNITY; MICROFLUIDICS; MICROTECHNOLOGY; NASAL BIOPSY; NASAL LAVAGE; NONHUMAN; NOSE MUCOSA; NOSE MUCUS; NOSE OBSTRUCTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW; ANIMAL; DRUG DESIGN; DRUG DEVELOPMENT; DRUG SCREENING; INFLAMMATION; PATHOPHYSIOLOGY; PROCEDURES;

ANIMALS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; DRUG DESIGN; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; HUMANS; INFLAMMATION; NASAL MUCOSA;

EID: 84901250675     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2014.909403     Document Type: Review

References (131)

1. Walsh GM. Novel cytokine-directed therapies for asthma. Discov Med 2011;11(59):283-91
2. Barnes PJ. New therapies for asthma: Is there any progress? Trends Pharmacol Sci 2010;31(7):335-43
3. Mullane K. The increasing challenge of discovering asthma drugs. Biochem Pharmacol 2011;82(6):586-99
4. Shapiro SD. Animal models of asthma: Pro: Allergic avoidance of animal (model [s]) is not an option. Am J Respir Crit Care Med 2006;174(11):1171-3 (Pubitemid 44924814
5. Shapiro SD. The use of transgenic mice for modeling airways disease Pulm Pharmacol Ther 2008;21(5):699-701
6. Swindle EJ, Davies DE. Artificial airways for the study of respiratory disease. Expert Rev Respir Med 2011;5(6):757-65
7. Wenzel S, Holgate ST. The mouse trap: It still yields few answers in asthma. Am J Respir Crit Care Med 2006;174(11):1173-6; discussion 76-8
8. Djukanovic R, Wilson JW, Lai CK, et al. The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. Am Rev Respir Dis 1991;143(4 Pt 1):772-7
9. ARIA (Allergic Rhinitis and its Impact on Asthma) initiative. 2014. Available from: Http://www.whiar.org
10. GINA (Global Initiative for Asthma). 2014. Available from: Http://www. ginasthma.org
11. Global Initiative for Asthma, GINA Report, Global Strategy for Asthma Management and Prevention (update). 2012. Available from: Http://ginasthma.org/ local/uploads/files/ GINA-Report-March13.pdf
12. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160
13. McDougall CM, Blaylock MG, Douglas JG, et al. Nasal epithelial cells as surrogates for bronchial epithelial cells in airway inflammation studies. Am J Respir Cell Mol Biol 2008;39(5):560-8
14. Jarvis D, Newson R, Lotvall J, et al. Asthma in adults and its association with chronic rhinosinusitis: The GA2LEN survey in Europe. Allergy 2012;67(1):91-8
15. Bousquet J, Van Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Suppl):S147-334
16. Grossman J. One airway, one disease. Chest 1997;111(2 Suppl):11S-6S (Pubitemid 27100613
17. American Thoracic Society Workshop. Immunobiology of asthma and rhinitis. Pathogenic factors and therapeutic options. Am J Respir Crit Care Med 1999;160(5 Pt 1):1778-87
18. Simons FE. Allergic rhinobronchitis: The asthma-Allergic rhinitis link. J Allergy Clin Immunol 1999;104(3 Pt 1):534-40
19. Bentley AM, Jacobson MR, Cumberworth V, et al. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: Increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol 1992;89(4):877-83
20. Pauwels R. Influence of treatment on the nose and/or the lungs. Clin Exp Allergy 1998;28(Suppl 2):37-40
21. Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 2002;109(4):636-42 (Pubitemid 34327190
22. Wilson AM, O'Byrne PM, Parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: A systematic review and meta-Analysis. Am J Med 2004;116(5):338-44 (Pubitemid 38230294
23. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003(4):CD001186
24. Vignola AM, Humbert M, Bousquet J, et al. Efficacy and tolerability of antiimmunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy 2004;59(7):709-17 (Pubitemid 38850345
25. Kopp MV, Brauburger J, Riedinger F, et al. The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis. J Allergy Clin Immunol 2002;110(5):728-35 (Pubitemid 35423175
26. Philip G, Nayak AS, Berger WE, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004;20(10):1549-58 (Pubitemid 39457543
27. Taramarcaz P, Gibson PG. Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis. Cochrane Database Syst Rev 2003(4):CD003570
28. Dahl R, Nielsen LP, Kips J, et al. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma. Allergy 2005;60(7):875-81 (Pubitemid 40813808
29. Dykewicz MS, Fineman S. Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. Ann Allergy Asthma Immunol 1998;81(5 Pt 2):463-8 (Pubitemid 28553775
30. Passalacqua G, Durham SR; Global Allergy and Asthma European Network. Allergic rhinitis and its impact on asthma update: Allergen immunotherapy. J Allergy Clin Immunol 2007;119(4):881-91
31. Till SJ, Francis JN, Nouri-Aria K, Durham SR. Mechanisms of immunotherapy. J Allergy Clin Immunol 2004;113(6):1025-34; quiz 35
32. Walker SM, Pajno GB, Lima MT, et al. Grass pollen immunotherapy for seasonal rhinitis and asthma: A randomized, controlled trial. J Allergy Clin Immunol 2001;107(1):87-93 (Pubitemid 32105250
33. Van Cauwenberge P. ARIA: Impact of compliance. Clin Exp Allergy Rev 2005;5(1):1472-9733
34. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126(3):466-76
35. Braunstahl GJ, Overbeek SE, Kleinjan A, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001;107(3):469-76 (Pubitemid 32210027
36. Serrano CD, Valero A, Bartra J, et al. Nasal and bronchial inflammation after nasal allergen challenge: Assessment using noninvasive methods. J Investig Allergol Clin Immunol 2012;22(5):351-6
37. Braunstahl GJ, Kleinjan A, Overbeek SE, et al. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000;161(6):2051-7 (Pubitemid 30418150
38. Varney VA, Jacobson MR, Sudderick RM, et al. Immunohistology of the nasal mucosa following allergeninduced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis 1992;146(1):170-6
39. Howarth PH, Persson CG, Meltzer EO, et al. Objective monitoring of nasal airway inflammation in rhinitis. J Allergy Clin Immunol 2005;115(3 Suppl 1):S414-41
40. Larche M. Immunoregulation by targeting T cells in the treatment of allergy and asthma. Curr Opin Immunol 2006;18(6):745-50 (Pubitemid 44635181
41. Compalati E, Passalacqua G, Bonini M, Canonica GW. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: Results of a GA2LEN meta-Analysis. Allergy 2009;64(11):1570-9
42. Hirsch T, Sahn M, Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 1997;8(1):21-7 (Pubitemid 27365651
43. Naclerio RM, Meier HL, Kagey-Sobotka A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128(4):597-602 (Pubitemid 13014103
44. Svensson C, Pipkorn U, Alkner U, et al. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways. Clin Exp Allergy 1992;22(3):411-16
45. Wilson SJ, Lau L, Howarth PH. Inflammatory mediators in naturally occurring rhinitis. Clin Exp Allergy 1998;28(2):220-7 (Pubitemid 28137338
46. Gosset P, Malaquin F, Delneste Y, et al. Interleukin-6 and interleukin-1 alpha production is associated with antigen-induced late nasal response. J Allergy Clin Immunol 1993;92(6):878-90
47. Howarth PH, Wilson S, Lau L, Rajakulasingam K. The nasal mast cell and rhinitis. Clin Exp Allergy 1991;21(Suppl 2):3-8
48. Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985;313(2):65-70 (Pubitemid 15068698
49. Knani J, Campbell A, Enander I, et al. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. J Allergy Clin Immunol 1992;90(6 Pt 1):880-9 (Pubitemid 23004584
50. Linden M, Svensson C, Andersson M, et al. Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis. Allergy 1999;54(3):212-19 (Pubitemid 29185281
51. Benson M, Strannegard IL, Wennergren G, Strannegard O. Low levels of interferon-gamma in nasal fluid accompany raised levels of T-helper 2 cytokines in children with ongoing allergic rhinitis. Pediatr Allergy Immunol 2000;11(1):20-8 (Pubitemid 30168881
52. Weido AJ, Reece LM, Alam R, et al. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis. Ann Allergy Asthma Immunol 1996;77(5):407-15 (Pubitemid 26422079
53. Kuna P, Lazarovich M, Kaplan AP. Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97(1 Pt 1):104-12 (Pubitemid 26045974
54. Salib RJ, Lau LC, Howarth PH. Nasal lavage fluid concentrations of eotaxin-1 (CCL11) in naturally occurring allergic rhinitis: Relationship to disease activity, nasal luminal eosinophil influx, and plasma protein exudation. Clin Exp Allergy 2005;35(8):995-1002 (Pubitemid 41603132
55. Pipkorn U, Proud D, Lichtenstein LM, et al. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med 1987;316(24):1506-10 (Pubitemid 17076234
56. Alam R, Sim TC, Hilsmeier K, Grant JA. Development of a new technique for recovery of cytokines from inflammatory sites in situ. J Immunol Methods 1992;155(1):25-9
57. Sim TC, Grant JA, Hilsmeier KA, et al. Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med 1994;149(2 Pt 1):339-44 (Pubitemid 24068977
58. Linden M, Svensson C, Andersson E, et al. Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of granulocytemacrophage colony-stimulating factor and interleukin-5. Am J Respir Crit Care Med 2000;162(5):1705-8
59. Erin EM, Neighbour H, Tan AJ, et al. Nasal testing for novel anti-inflammatory agents. Clin Exp Allergy 2005;35(8):981-5 (Pubitemid 41603130
60. Pipkorn U, Karlsson G. Methods for obtaining specimens from the nasal mucosa for morphological and biochemical analysis. Eur Respir J 1988;1(9):856-62
61. Pipkorn U, Karlsson G, Enerback L. A brush method to harvest cells from the nasal mucosa for microscopic and biochemical analysis. J Immunol Methods 1988;112(1):37-42
62. Jacobson MR, Juliusson S, Lowhagen O, et al. Effect of topical corticosteroids on seasonal increases in epithelial eosinophils and mast cells in allergic rhinitis: A comparison of nasal brush and biopsy methods. Clin Exp Allergy 1999;29(10):1347-55 (Pubitemid 29467958
63. van Benten IJ, Van Drunen CM, Koevoet JL, et al. Reduced nasal IL-10 and enhanced TNFalpha responses during rhinovirus and RSV-induced upper respiratory tract infection in atopic and non-Atopic infants. J Med Virol 2005;75(2):348-57 (Pubitemid 40053749
64. Stoop AE, Hameleers DM, v Run PE, et al. Lymphocytes and nonlymphoid cells in the nasal mucosa of patients with nasal polyps and of healthy subjects. J Allergy Clin Immunol 1989;84(5 Pt 1):734-41 (Pubitemid 20008505
65. Fokkens WJ, Vroom TM, Gerritsma V, Rijntjes E. A biopsy method to obtain high quality specimens of nasal mucosa. Rhinology 1988;26(4):293-5 (Pubitemid 19022669
66. Jeffery P, Holgate S, Wenzel S; Endobronchial Biopsy Workshop. Methods for the assessment of endobronchial biopsies in clinical research: Application to studies of pathogenesis and the effects of treatment. Am J Respir Crit Care Med 2003;168(6 Pt 2):S1-17
67. Cohen GA, MacPherson GA, Golembesky HE, et al. Normal nasal cytology in infancy. Ann Allergy 1985;54(2):112-14 (Pubitemid 15132933
68. Ventura MT, Murgia N, Montuschi P, et al. Exhaled breath condensate, nasal eosinophil cationic protein level and nasal cytology during immunotherapy for cypress allergy. J Biol Regul Homeost Agents 2013;27(4):1083-9
69. Bascom R, Wachs M, Naclerio RM, et al. Basophil influx occurs after nasal antigen challenge: Effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988;81(3):580-9 (Pubitemid 18089940
70. Connell JT. Nasal disease: Mechanisms and classification. Ann Allergy 1983;50(4):227-35 (Pubitemid 13124997
71. Meltzer EO. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol 1998;81(2):128-34 (Pubitemid 28413027
72. Meltzer EO, Orgel HA, Rogenes PR, Field EA. Nasal cytology in patients with allergic rhinitis: Effects of intranasal fluticasone propionate. J Allergy Clin Immunol 1994;94(4):708-15 (Pubitemid 24326152
73. Furin MJ, Norman PS, Creticos PS, et al. Immunotherapy decreases antigeninduced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol 1991;88(1):27-32
74. Cengizlier R, Saraclar Y, Adalioglu C, Tuncer A. Changes in nasal metachromatic cells during allergen immunotherapy in children. Allergol Immunopathol (Madr) 1995;23(3):111-16
75. Otsuka H, Mezawa A, Ohnishi M, et al. Changes in nasal metachromatic cells during allergen immunotherapy. Clin Exp Allergy 1991;21(1):115-19
76. Francis JN, Durham SR. Adjuvants for allergen immunotherapy: Experimental results and clinical perspectives. Curr Opin Allergy Clin Immunol 2004;4(6):543-8 (Pubitemid 39573730
77. Javanmard SH, Moeiny A. Quantitative immunohistochemistry by measuring chromogen signal strength using a C# written program. J Res Med Sci 2009;14(3):201-3
78. Matkowskyj KA, Schonfeld D, Benya RV. Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software photoshop and matlab. J Histochem Cytochem 2000;48(2):303-12
79. Kamentsky L, Jones TR, Fraser A, et al. Improved structure, function and compatibility for CellProfiler: Modular high-Throughput image analysis software. Bioinformatics 2011;27(8):1179-80
80. Carpenter AE, Jones TR, Lamprecht MR, et al. CellProfiler: Image analysis software for identifying and quantifying cell phenotypes. Genome Biol 2006;7(10):R100
81. Langdale JA. In situ hybridization. In: The maize handbook. Springer, New York; 1994. p. 165-80
82. Martineau B, Taylor WC. Cell-specific photosynthetic gene expression in maize determined using cell separation techniques and hybridization in situ. Plant Physiol 1986;82(2):613-18
83. Durham SR, Ying S, Varney VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/ macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia. J Immunol 1992;148(8):2390-4
84. Ghaffar O, Laberge S, Jacobson MR, et al. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: Comparison with IL-4 expression and modulation by topical glucocorticoid therapy. Am J Respir Cell Mol Biol 1997;17(1):17-24 (Pubitemid 127500816
85. Divjak M, Glare EM, Walters EH. Improvement of non-radioactive in situ hybridization in human airway tissues: Use of PCR-generated templates for synthesis of probes and an antibody sandwich technique for detection of hybridization. J Histochem Cytochem 2002;50(4):541-8 (Pubitemid 34250593
86. Chanez P, Vignola AM, Vic P, et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med 1999;159(2):588-95 (Pubitemid 29084885
87. Gelfand EW. Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol 2004;114(5 Suppl):S135-8
88. Pierrou S, Broberg P, O'Donnell RA, et al. Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175(6):577-86 (Pubitemid 46438942
89. Gray TE, Guzman K, Davis CW, et al. Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. Am J Respir Cell Mol Biol 1996;14(1):104-12 (Pubitemid 126443096
90. Jain R, Pan J, Driscoll JA, et al. Temporal relationship between primary and motile ciliogenesis in airway epithelial cells. Am J Respir Cell Mol Biol 2010;43(6):731-9
91. Choe MM, Tomei AA, Swartz MA. Physiological 3D tissue model of the airway wall and mucosa. Nat Protoc 2006;1(1):357-62
92. Wu X, Peters-Hall JR, Bose S, et al. Human bronchial epithelial cells differentiate to 3D glandular acini on basement membrane matrix. Am J Respir Cell Mol Biol 2011;44(6):914-21
93. Klein SG, Serchi T, Hoffmann L, et al. An improved 3D tetraculture system mimicking the cellular organisation at the alveolar barrier to study the potential toxic effects of particles on the lung. Part Fibre Toxicol 2013;10(1):31
94. Drumm K, Messner C, Kienast K. Reactive oxygen intermediate-release of fibre-exposed monocytes increases inflammatory cytokine-mRNA level, protein tyrosine kinase and NF-kappaB activity in co-cultured bronchial epithelial cells (BEAS-2B). Eur J Med Res 1999;4(7):257-63
95. Mio T, Liu XD, Adachi Y, et al. Human bronchial epithelial cells modulate collagen gel contraction by fibroblasts. Am J Physiol 1998;274(1 Pt 1):L119-26
96. Jeanson L, Kelly M, Coste A, et al. Oxidative stress induces unfolding protein response and inflammation in nasal polyposis. Allergy 2012;67(3):403-12
97. Wise SK, Laury AM, Katz EH, et al. Interleukin-4 and interleukin-13 compromise the sinonasal epithelial barrier and perturb intercellular junction protein expression. Int Allergy Rhinol 2014. [Epub ahead of print]
98. Yeh TH, Lee SY, Hsu WC. Expression of SPLUNC1 protein in nasal polyp epithelial cells in air-liquid interface culture treated with IL-13. Am J Rhinol Allergy 2010;24(1):17-20
99. Choe MM, Sporn PH, Swartz MA. Extracellular matrix remodeling by dynamic strain in a three-dimensional tissue-engineered human airway wall model. Am J Respir Cell Mol Biol 2006;35(3):306-13 (Pubitemid 44353398
100. Zhang S, Smartt H, Holgate ST, Roche WR. Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: An in vitro co-culture model of airway remodeling in asthma. Lab Invest 1999;79(4):395-405 (Pubitemid 29190429
101. Jaffar Z, Roberts K, Pandit A, et al. 7 costimulation is required for IL-5 and IL-13 secretion by bronchial biopsy tissue of atopic asthmatic subjects in response to allergen stimulation. Am J Respir Cell Mol Biol 1999;20(1):153-62 (Pubitemid 129504854
102. Hidi R, Riches V, Al-Ali M, et al. Role of B7-CD28/CTLA-4 costimulation and NF-kappa B in allergen-induced T cell chemotaxis by IL-16 and RANTES. J Immunol 2000;164(1):412-18 (Pubitemid 30013016
103. Dent G, Hosking LA, Lordan JL, et al. Differential roles of IL-16 and CD28/ B7 costimulation in the generation of T-lymphocyte chemotactic activity in the bronchial mucosa of mild and moderate asthmatic individuals. J Allergy Clin Immunol 2002;110(6):906-14 (Pubitemid 36005879
104. Vijayanand P, Durkin K, Hartmann G, et al. Chemokine receptor 4 plays a key role in T cell recruitment into the airways of asthmatic patients. J Immunol 2010;184(8):4568-74
105. Lu X, Zhang XH, Wang H, et al. Expression of osteopontin in chronic rhinosinusitis with and without nasal polyps. Allergy 2009;64(1):104-11
106. Patou J, Gevaert P, Van Zele T, et al. Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol 2008;121(1):110-15
107. Chen B, Antunes MB, Claire SE, et al. Reversal of chronic rhinosinusitisassociated sinonasal ciliary dysfunction. Am J Rhinol 2007;21(3):346-53 (Pubitemid 46991965
108. Chen B, Shaari J, Claire SE, et al. Altered sinonasal ciliary dynamics in chronic rhinosinusitis. Am J Rhinol 2006;20(3):325-9 (Pubitemid 44083416
109. Huh D, Hamilton GA, Ingber DE. From 3D cell culture to organs-on-chips. Trends Cell Biol 2011;21(12):745-54
110. Huh D, Matthews BD, Mammoto A, et al. Reconstituting organ-level lung functions on a chip. Science 2010;328(5986):1662-8
111. Huh D, Fujioka H, Tung YC, et al. Acoustically detectable cellular-level lung injury induced by fluid mechanical stresses in microfluidic airway systems. Proc Natl Acad Sci USA 2007;104(48):18886-91
112. Nalayanda DD, Puleo C, Fulton WB, et al. An open-Access microfluidic model for lung-specific functional studies at an air-liquid interface. Biomed Microdevices 2009;11(5):1081-9
113. Trist DG. Scientific process, pharmacology and drug discovery. Curr Opin Pharmacol 2011;11(5):528-33
114. Orloff J, Douglas F, Pinheiro J, et al. The future of drug development: Advancing clinical trial design. Nat Rev Drug Discov 2009;8(12):949-57
115. Diamant Z, Boot D, Kamerling I, Bjermer L. Methods used in clinical development of novel anti-Asthma therapies. Respir Med 2008;102(3):332-8 (Pubitemid 351179985
116. Lodrup Carlsen KC, Hedlin G, Bush A, et al. Assessment of problematic severe asthma in children. Eur Respir J 2011;37(2):432-40
117. Holgate ST. Stratified approaches to the treatment of asthma. Br J Clin Pharmacol 2013;76(2):277-91
118. Healey GD, Evans N, Hopkin JM, et al. Evaluation of nasal epithelium sampling as a tool in the preclinical development of siRNA-based therapeutics for asthma. J Cell Mol Med 2013;17(3):356-64
119. Comer DM, Elborn JS, Ennis M. Comparison of nasal and bronchial epithelial cells obtained from patients with COPD. PLoS One 2012;7(3):e32924
120. Mauad T, Dolhnikoff M. Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2008;14(1):31-8 (Pubitemid 350191036
121. Carroll N, Elliot J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 1993;147(2):405-10 (Pubitemid 23044915
122. Chung KF. Airway smooth muscle cells: Contributing to and regulating airway mucosal inflammation? Eur Respir J 2000;15(5):961-8
123. Calzetta L, Passeri D, Kanabar V, et al. Brain natriuretic peptide protects against hyperreactivity of human asthmatic airway smooth muscle via an epithelial cell dependent mechanism. Am J Respir Cell Mol Biol 2014;50(3):493-501
124. Calzetta L, Page CP, Spina D, et al. Effect of the mixed phosphodiesterase 3/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone. J Pharmacol Exp Ther 2013;346(3):414-23
125. Matera MG, Calzetta L, Passeri D, et al. Epithelial-smooth muscle cooperation is needed for brain natriuretic peptidedependent bronchorelaxant activity. Pulm Pharmacol Ther 2013;26(1):156-7
126. Calzetta L, Spina D, Cazzola M, et al. Pharmacological characterization of adenosine receptors on isolated human bronchi. Am J Respir Cell Mol Biol 2011;45(6):1222-31
127. Matera MG, Calzetta L, Passeri D, et al. Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi. Br J Pharmacol 2011;163(8):1740-54
128. Matera MG, Calzetta L, Parascandolo V, et al. Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi. Pulm Pharmacol Ther 2009;22(6):478-82
129. Matera MG, Calzetta L, Peli A, et al. Immune sensitization of equine bronchus: Glutathione, IL-1beta expression and tissue responsiveness. Respir Res 2005;6:104
130. van Lunteren E, Moyer M. Auxotonic contractile responses of rat tracheal and bronchial airway smooth muscle. Pulm Pharmacol Ther 2001;14(6):443-53 (Pubitemid 34081696
131. Wohlsen A, Uhlig S, Martin C. Immediate allergic response in small airways. Am J Respir Crit Care Med 2001;163(6):1462-9 (Pubitemid 32506617